New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 16, 2012
06:28 EDTISRGIntuitive Surgical initiated with a Buy at SunTrust
Target $598.
News For ISRG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2015
07:17 EDTISRGSociety of Thoracic Surgeons to hold annual meeting
51st Annual Meeting of STS is being held in San Diego, California on January 24-28.
January 23, 2015
09:05 EDTISRGIntuitive Surgical 2015 EPS likely to beat guidance, says SunTrust
Subscribe for More Information
08:00 EDTISRGIntuitive Surgical shares likely to see pressure, says Leerink
Subscribe for More Information
January 22, 2015
17:05 EDTISRGIntuitive Surgical reverses to decline 3.7% after procedure guidance
Subscribe for More Information
16:59 EDTISRGIntuitive Surgical anticipates currency headwinds in 2015
16:58 EDTISRGIntuitive Surgical sees FY15 gross profit margin similar to Q4
Subscribe for More Information
16:57 EDTISRGIntuitive Surgical sees 2015 procedural growth 7%-10%
Subscribe for More Information
16:54 EDTISRGIntuitive Surgical encouraged by clinical developments in Europe
Subscribe for More Information
16:51 EDTISRGIntuitive Surgical says Q4 U.S procedures grew 8%, international grew 21%
Subscribe for More Information
16:39 EDTISRGIntuitive Surgical received regulatory clearance for da Vinci Xi system in Korea
Subscribe for More Information
16:07 EDTISRGIntuitive Surgical Q4 worldwide da Vinci procedures grew nearly 10% YoY
The company placed 137 da Vinci Surgical Systems, compared to 138 in the fourth quarter of 2013 and 111 in the third quarter of 2014.
16:06 EDTISRGIntuitive Surgical reports Q4 EPS $4.92, consensus $4.38
Reports Q4 non-GAAP revenue $601M, consensus $589.37M.
15:32 EDTISRGNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Starbucks (SBUX), consensus 80c; Capital One (COF), consensus $1.74; Intuitive Surgical (ISRG), consensus $4.38; KLA-Tencor (KLAC), consensus 52c; Altera (ALTR), consensus 35c; E-Trade (ETFC), consensus 23c... ResMed (RMD), consensus 62c; Maxim Integrated Products (MXIM), consensus 30c; Maxim Integrated Products (MSCC), consensus 65c; Hexcel (HXL), consensus 54c; Polycom (PLCM), consensus 23c; Skyworks (SWKS), consensus $1.19; Curtiss-Wright (CW), consensus $1.00.
15:05 EDTISRGIntuitive Surgical January weekly 525 straddle priced for 5.4% movement into Q4
12:52 EDTISRGEarnings Preview: Intuitive Surgical sees Q4 da Vinci sales up 5% on GAAP basis
Subscribe for More Information
12:10 EDTISRGIntuitive Surgical technical comments before results
The shares have been in a consolidation phase for the last month ahead of results. The low of the recent range is at $513 and the high of the range is at $538. Breaks of either end of this range will likely determine the future price path of the shares. A breakout above $538 on positive news would likely also tick the 52-week high at $541.23. Resistance levels to watch thereafter would be at $550, $567, and $574. A breakdown below the low of the range on a negative surprise would be bearish for future price. Below $513 next supports would be at $496.66, $486.61, and $467.26. The stock does have a history of extreme price reactions around earnings exacerbated by the small trading float. As of the last available report, the short-base in the name was neutral and relatively low compared to prior history.
January 21, 2015
08:40 EDTISRGIntuitive Surgical January weekly volatility elevated into Q4 and outlook
Subscribe for More Information
January 15, 2015
10:19 EDTISRGOptions with decreasing implied volatility
Subscribe for More Information
January 13, 2015
08:40 EDTISRGIntuitive Surgical reports preliminary Q4 revenue $605M, consensus $587.48M
Intuitive Surgical announced certain unaudited preliminary Q4 financial results. The company expects GAAP revenue for Q4 of approximately $605M, up approximately 5% from $576M for the 4Q13. The company expects non-GAAP revenue for Q4 of approximately $601M, which excludes approximately $4M of revenue associated with da Vinci Xi trade-out offers. The unaudited preliminary results are prior to the completion of our annual independent audit and therefore are subject to adjustment. Preliminary Q4 instruments and accessories revenue on a GAAP basis is expected to increase approximately 5% to approximately $281M from $268M during 4Q13. Preliminary fourth quarter 2014 da Vinci Surgical Systems revenue on a GAAP basis is expected to increase approximately 5% to approximately $214M from $205M during 4Q13. The company placed 137 da Vinci Surgical Systems during Q4, compared with 138 systems during 4Q13. The Preliminary Q4 GAAP service revenue is expected to increase approximately 6% to approximately $110M from $103M during 4Q13.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use